01-Aug-2001
The Lipids in Diabetes Study (LDS) ended prematurely when Bayer unexpectedly withdrew their cholesterol lowering drug, cerivastatin, in August 2001.
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ Tel: +44 (0)1865 857242 Email: dtu@dtu.ox.ac.uk Home | Intranet | Freedom of information | Privacy notice | Copyright | Accessibility | OCDEM | RDM | Oxford University